| Lactose (India) Ltd | 131 Cr. | 104 | 214/84.3 | 28.9 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,541 Cr. | 417 | 479/192 | 94.0 | 24.3 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.9 Cr. | 44.3 | 87.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 55.8 Cr. | 38.1 | 39.1/17.0 | 133 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 67.3 Cr. | 89.4 | 119/69.7 | 18.2 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 60,042 Cr. | 2,128 | 2,286/1,275 | 23.9 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 333 Cr. | 13.7 | 18.0/10.8 | 20.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 17.6/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 834 Cr. | 1,555 | 1,999/635 | 28.9 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 94.8 Cr. | 19.0 | 32.0/17.0 | 25.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,012 Cr. | 344 | 449/219 | 9.07 | 133 | 0.74 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.91 Cr. | 13.8 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.29 Cr. | 3.33 | 8.28/2.11 | 4.70 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 493 Cr. | 508 | 536/211 | 74.5 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,143 Cr. | 1,182 | 1,565/944 | 46.5 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 53.2 Cr. | 0.26 | 1.12/0.24 | 3.51 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 38.4 Cr. | 14.6 | 26.3/11.4 | 18.7 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.72 Cr. | 9.63 | 15.9/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 164 Cr. | 460 | 851/429 | 9.29 | 596 | 0.32 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 89.8 Cr. | 89.8 | 92.5/26.1 | 169 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,688 Cr. | 1,404 | 2,452/1,297 | 45.7 | 174 | 0.75 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 24.2 Cr. | 53.0 | 88.7/36.1 | 52.6 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.5 Cr. | 5.39 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 22.0 Cr. | 147 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 72.1 Cr. | 132 | 144/9.41 | 49.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 29.6 Cr. | 39.2 | 73.0/33.0 | 47.7 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.93 Cr. | 19.8 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,212 Cr. | 531 | 1,028/512 | 26.1 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 85.9 Cr. | 19.9 | 32.6/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.8 | 43.0/17.4 | 50.2 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 94,326 Cr. | 2,285 | 2,945/2,090 | 56.6 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 241 Cr. | 418 | 524/241 | 24.7 | 123 | 1.07 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 60.7 Cr. | 42.3 | 48.2/26.7 | 94.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 72,972 Cr. | 1,256 | 1,307/994 | 21.3 | 603 | 0.32 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 150 Cr. | 241 | 303/159 | 143 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 790 Cr. | 78.8 | 115/74.0 | 20.4 | 32.6 | 1.90 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 37.6 Cr. | 28.8 | 44.9/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,504 Cr. | 1,772 | 1,902/919 | 64.8 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.30 Cr. | 0.65 | 1.24/0.51 | 107 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 218 Cr. | 28.5 | 57.4/26.0 | 14.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.66 Cr. | 9.67 | 20.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 134 Cr. | 5.68 | 6.57/2.82 | 311 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 60,553 Cr. | 28,496 | 37,000/25,260 | 40.1 | 1,888 | 1.67 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,797 Cr. | 750 | 972/557 | 28.3 | 226 | 0.66 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 195 Cr. | 68.6 | 100/31.3 | 54.4 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,952 Cr. | 1,493 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,933 Cr. | 1,473 | 1,870/1,110 | 436 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 788 Cr. | 226 | 330/154 | 18.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 96.4 Cr. | 11.6 | 29.4/11.6 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,000 Cr. | 748 | 849/270 | 15.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,070 Cr. | 436 | 791/418 | 21.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,439 Cr. | 1,018 | 1,402/991 | 20.4 | 768 | 0.98 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,36,397 Cr. | 4,030 | 4,036/2,886 | 63.0 | 250 | 0.80 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 966 Cr. | 105 | 284/98.0 | | 41.3 | 0.48 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,316 Cr. | 14.0 | 23.5/13.7 | 21.0 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 19,559 Cr. | 511 | 1,328/500 | 56.9 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,936 Cr. | 173 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,31,100 Cr. | 1,797 | 1,870/1,547 | 37.2 | 324 | 0.92 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,607 Cr. | 580 | 734/441 | 407 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,225 Cr. | 344 | 348/175 | 39.8 | 81.2 | 0.12 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,259 Cr. | 320 | 502/265 | 40.5 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 9,120 Cr. | 209 | 260/111 | 211 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,716 Cr. | 4,219 | 6,718/4,050 | 26.3 | 340 | 2.79 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,892 Cr. | 2,353 | 2,725/1,772 | 34.9 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,503 Cr. | 5,725 | 6,739/4,904 | 31.0 | 373 | 2.18 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 170 Cr. | 48.2 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,841 Cr. | 4,993 | 5,993/3,701 | 32.3 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 121 Cr. | 98.3 | 212/81.0 | 12.5 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,265 Cr. | 370 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,998 Cr. | 788 | 1,915/604 | 76.5 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,102 Cr. | 14,889 | 19,748/10,060 | 97.6 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 434 Cr. | 19.3 | 41.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,986 Cr. | 948 | 1,341/660 | 11.0 | 483 | 0.64 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,256 Cr. | 41.2 | 75.8/38.4 | 29.9 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,241 Cr. | 182 | 295/162 | 23.4 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 55.7 Cr. | 35.2 | 130/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 293 Cr. | 82.0 | 164/72.2 | 143 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,00,557 Cr. | 2,201 | 2,373/1,774 | 23.3 | 430 | 0.55 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 962 Cr. | 480 | 850/464 | 12.0 | 357 | 0.38 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 61,155 Cr. | 1,133 | 1,134/501 | 89.6 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,213 Cr. | 1,169 | 1,235/596 | 24.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 150 Cr. | 69.4 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 748 Cr. | 155 | 216/123 | 42.5 | 104 | 1.93 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 616 Cr. | 352 | 500/265 | 22.3 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,302 Cr. | 1,086 | 1,250/802 | 34.8 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,739 Cr. | 1,898 | 1,918/1,303 | 41.4 | 243 | 0.83 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,260 Cr. | 189 | 302/185 | 28.8 | 38.0 | 1.32 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,547 Cr. | 1,480 | 1,749/1,168 | 37.9 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,408 Cr. | 82.0 | 127/57.5 | 20.7 | 59.7 | 0.97 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 30.2/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 728 Cr. | 89.2 | 124/67.2 | 24.5 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,107 Cr. | 228 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,753 Cr. | 223 | 457/217 | 273 | 96.9 | 0.63 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,357 Cr. | 1,595 | 2,390/1,243 | 31.0 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,287 Cr. | 328 | 495/285 | 60.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,906 Cr. | 614 | 627/412 | 29.2 | 164 | 0.25 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 58,825 Cr. | 2,084 | 2,286/1,275 | 23.4 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,013 Cr. | 2,480 | 3,516/1,921 | 44.1 | 101 | 1.69 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,884 Cr. | 1,692 | 2,131/1,200 | 24.1 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,718 Cr. | 413 | 528/359 | 29.8 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,141 Cr. | 1,552 | 1,910/1,097 | 50.8 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,846 Cr. | 1,256 | 1,406/1,020 | 18.2 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,025 Cr. | 257 | 322/178 | 26.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,23,654 Cr. | 1,531 | 1,673/1,310 | 22.7 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,973 Cr. | 1,838 | 2,602/1,551 | 23.7 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 225 Cr. | 76.3 | 192/68.1 | 16.1 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,930 Cr. | 182 | 192/105 | 17.6 | 107 | 0.27 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.8 Cr. | 33.7 | 62.9/32.2 | 19.2 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,493 Cr. | 385 | 425/291 | 109 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,680 Cr. | 1,664 | 2,000/1,430 | 37.1 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 116 Cr. | 73.0 | 129/67.2 | 17.0 | 49.2 | 1.64 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 349 Cr. | 148 | 205/67.8 | 33.0 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,000 Cr. | 8,400 | 10,691/6,502 | 90.8 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,895 Cr. | 655 | 843/544 | 33.4 | 118 | 0.70 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 160 Cr. | 75.9 | 137/73.6 | 8.48 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,620 Cr. | 5,656 | 5,868/4,492 | 28.8 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,230 Cr. | 826 | 1,110/725 | 25.6 | 271 | 1.33 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 426 Cr. | 746 | 1,355/730 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 35,537 Cr. | 2,844 | 3,080/2,022 | 36.5 | 345 | 0.98 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,442 Cr. | 308 | 367/258 | 23.4 | 133 | 1.69 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,663 Cr. | 402 | 575/312 | 19.2 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,894.26 Cr | 1,156.17 | | 54.51 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |